Additionally, the significance of investigating the effect of mifepristone in oral cancer also stems from the strong relationship between alcohol consumption [40] and oral cancer, as well as the increased prevalence of stress in patients with oral cancer [41], and how mifepristone as a GR antagonist may potentially contribute to suppression of alcohol craving. Here, NR3C1 is linked to lip and oral cavity carcinoma.